July 10th 2010
Tags:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Healthcare,
Medicine,
Pharmaceuticals,
Science
No Comments
Cryo-Cell International, Inc. a global leader in stem cell innovation, resolves to help women inspire and empower each other to take charge of their health in the New Year, and to spark conversations about the promise of stem cells. The company will be accepting video entries for its “Resolution Revolution” ...
July 10th 2010
Tags:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Healthcare,
Medicine,
Pharmaceuticals,
Science
No Comments
For an expectant mother, there are a million details to worry about and a lot of important decisions to be made.
One of those decisions to be made is whether to bank your baby's umbilical cord blood. Cord blood is valuable because it's full of stem cells scientists and doctors can use ...
July 10th 2010
Tags:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Healthcare,
Medicine,
Pharmaceuticals,
Science
No Comments
Dr. Joshua Hare believes medicine is close to a goal long thought to be impossible: healing the human heart.
The way to get there? Stem cells.
"These could be as big as antibiotics were in the last century," said Hare, who leads the University of Miami 's new Stem Cell Institute. "Stem ...
July 10th 2010
Tags:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Healthcare,
Medicine,
Pharmaceuticals,
Science
No Comments
Researchers from Italy have reported that the injection of umbilical cord blood directly into the pelvic bones of patients with leukemia appears promising. These results were recently published in an early online publication of the Lancet Oncology on August 9, 2008.
Transplantation of bone marrow, peripheral blood stem cells, and umbilical cord blood is ...
July 10th 2010
Tags:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Healthcare,
Medicine,
Pharmaceuticals,
Science
No Comments
Women in the city will soon have the option of banking their menstrual blood so that menstrual blood stem cells can be used for treatment of serious disorders through stem cell therapy.
In six months, Life Cell International, in technology partnership with Cryo-Cell International, will set up the facility, which will be ...
On August 23-25, 2010, industry scientists, CEOs, and academics will convene at Philadelphia’s Four Seasons Hotel for the “Ubiquitin Drug Discovery and Diagnostics Conference” to discuss the Next Big Thing in drug discovery research—the ubiquitin pathway. Advances in oncology, infectious diseases, neurodegeneration, inflammation, diabetes, and muscle wasting will be covered.
A ...
A new website by The United Soybean Board (USB) highlights the important role biotechnology plays in allowing U.S. farmers to continue to meet the world’s food demand as well as ensuring our environment and food supply remains as safe as ever. Whether you know it as biotech, genetically modified or ...
May 13th 2010
Tags:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Healthcare,
Medicine,
Pharmaceuticals,
Science
No Comments
Cryo-Cell International, Inc. today announced results of a study published [this month] in the cover article of Stem Cells and Developmentshowing that stem cells found in menstrual blood may one day be a potential source for stem cell therapies in stroke and other central nervous system disorders. Menstrual stem cells, known as ...
LC Sciences today announced the launch of its new Seq-Array(SM) services designed to take full advantage of both the latest deep sequencing capabilities and the proven genomics tool – microarray. This combination of technologies advances microRNA research to the next level of depth and understanding that was not possible before ...
Catalent Pharma Solutions will host a free webinar featuring Principal Scientist, Alan D. Hendricker, Ph.D. The one-hour webinar provides an introduction to the regulatory documents surrounding leachables and extractables testing requirements for pharmaceutical products intended for US submission. The presentation, titled “Leachables and Extractables: Regulatory Context,” will be held on ...
Gregory T. Bleck, PhD., Senior Director of Cell Line Engineering for Catalent Pharma Solutions, will be co-chairing the Cell Line Development and Engineering conference being held in San Francisco, California on February 25-26, 2010.
In addition to co-chairing the conference, Dr. Bleck will be presenting "Characteristics of an Effective Mammalian Cell ...
January 19th 2010
Tags:
Biomedical Engineering,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Healthcare,
Medicine,
Pharmaceuticals,
Science
No Comments
In a collaborative publication in the prestigious journal Blood that appears this week, PharmaCell BV, the Maastricht University, Institute for Research in Biomedicine in Switzerland and the Research Center for Allergy and Immunology in Japan present data on a novel approach to improve treatment of acute leukemia patients. In a study ...
Catalent Pharma Solutions has acquired advanced fine powder filling capability, which solidifies Catalent’s position as a leader in development and manufacturing services to the pharmaceutical inhalation sector. With the purchase of Harro Höfliger’s Omnidose filling equipment, Catalent now offers its customers fully scaleable dry powder inhaler (DPI) filling capability. This ...
Ana T. Menendez, Ph.D., Senior Director of Biotechnology at Catalent Pharma Solutions, will lead a two-day international course on immunogenicity. The course will take place at the Regus Victoria in London on Wednesday, December 2 through Thursday, December 3, 2009.
The interactive course, titled “Introduction to Immunogenicity,” will enable attendees to better ...
Ana T. Menendez, Ph.D., Senior Director of Biotechnology at Catalent Pharma Solutions, will be leading a course in Bioassay Method Development and Validation. The course is being offered through IBC Life Science on November 12-13, 2009 in Boston, MA.
Menendez will present a lecture outlining sensible approaches to developing reproducible bioassays using live ...
Catalent Pharma Solutions, a leading provider of advanced technologies and outsourced development and clinical services to the global pharmaceutical and biotechnology industry, has announced the development of the Galacorin™ molecule, a proprietary form of the decorin molecule.
Catalent combined its proprietary GPEx® gene expression technology, Triplet-FixTM codon optimization technology and advanced scientific ...
Taking full advantage of its flexible µParaflo® Biochip Technology, Houston based LC Sciences today announced immediate availability of probe content from the newly created Plant MicroRNA Database (PMRD) for their microRNA (miRNA) microarray customers . This announcement comes immediately following a publication in Nucleic Acids Researchintroducing the public database 1 . ...
LC Sciences announced today the publication of the 100th peer-reviewed study by one of its customers using the company’s microarray service for analyzing microRNA (miRNA) expression profiles and for discovery of novel small RNAs. These studies, by leading researchers in the field, contribute to a fast growing body of knowledge defining ...
Ana T. Menendez, Ph.D., Senior Director of Biotechnology at Catalent Pharma Solutions, will be teaching a pre-conference workshop titled "Detection and Characterization of Immunogenicity of Therapeutic Biologics" on Monday, September 7, 2009 in Prague, Czech Republic. The course will focus on the practical technologies used to measure antibody responses to ...
Dr. Jenkins’ talk will focus on Catalent’s proprietary GPEx technology for mammalian cell culture engineering. The 2009 BIO International Convention takes place in Atlanta, GA, May 18-21.
Dr. Jenkins’ presentation is titled “Bench to the Clinic: Using GPEx® Mammalian Cell Culture Engineering to Shorten Timelines, Reduce Risk, and Prepare for Success.” ...